Abstract
The Rab family of GTPases contains over 60 genes in the human genome and contributes to regulation of intracellular membrane trafficking along endocytic and exocytic pathways as well as specialized pathways in specific cell types. It has become increasingly clear that disruption of the intracellular membrane trafficking system at different stages can cause various diseases. In the past decade, altered expression levels and mutations of Rab GTPases have been associated with diseases such as cancer, Alzheimers disease, and various genetic disorders. This review discusses the specific Rab GTPases and their involvement in the diseases.
Keywords: Rab, GTPase, GTP-binding protein, cancer, genetic disorder, Alzheimer's disease, Carpenter syndrome, Griscelli syndrome, Hermansky-Pudlak Syndrome, mental retardation
Current Drug Targets
Title: Rab GTPases, Membrane Trafficking and Diseases
Volume: 12 Issue: 8
Author(s): Guangpu Li
Affiliation:
Keywords: Rab, GTPase, GTP-binding protein, cancer, genetic disorder, Alzheimer's disease, Carpenter syndrome, Griscelli syndrome, Hermansky-Pudlak Syndrome, mental retardation
Abstract: The Rab family of GTPases contains over 60 genes in the human genome and contributes to regulation of intracellular membrane trafficking along endocytic and exocytic pathways as well as specialized pathways in specific cell types. It has become increasingly clear that disruption of the intracellular membrane trafficking system at different stages can cause various diseases. In the past decade, altered expression levels and mutations of Rab GTPases have been associated with diseases such as cancer, Alzheimers disease, and various genetic disorders. This review discusses the specific Rab GTPases and their involvement in the diseases.
Export Options
About this article
Cite this article as:
Li Guangpu, Rab GTPases, Membrane Trafficking and Diseases, Current Drug Targets 2011; 12 (8) . https://dx.doi.org/10.2174/138945011795906561
DOI https://dx.doi.org/10.2174/138945011795906561 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteasome Regulators: Activators and Inhibitors
Current Medicinal Chemistry Reposition of the Fungicide Ciclopirox for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Targeting Glioblastoma Stem Cells: Cell Surface Markers
Current Medicinal Chemistry Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design Genetics of Preneoplasia: Lessons from Lung Cancer
Current Molecular Medicine An Overview of Nanoformulated Nutraceuticals and their Therapeutic Approaches
Current Nutrition & Food Science Alternative Splicing Regulates Pluripotent State in Pluripotent Stem Cells
Current Stem Cell Research & Therapy Analysis of Simple Sequence Repeats in Mammalian Cell Cycle Genes
Recent Advances in DNA & Gene Sequences (Discontinued) Integrins: Regulators of Tissue Function and Cancer Progression
Current Pharmaceutical Design Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
Current Pharmaceutical Design Biological Rationales and Clinical Applications of Temperature Controlled Hyperthermia - Implications for Multimodal Cancer Treatments
Current Medicinal Chemistry Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation
Current Genomics Gene Therapy in Plastic and Reconstructive Surgery
Current Gene Therapy Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Current Protein & Peptide Science Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer
Current Drug Discovery Technologies Characterization of the Prostaglandin E2 Pathway in a Rat Model of Esophageal Adenocarcinoma
Current Cancer Drug Targets Development of Peptides as Potential Drugs for Cancer Therapy
Current Pharmaceutical Design Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Clinical Cancer Drugs Beta-adrenergic Signaling in the Development and Progression of Pulmonary and Pancreatic Adenocarcinoma
Current Cancer Therapy Reviews Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
Current Cancer Drug Targets